High-Resolution Photon-Counting CT Detects Lung Microvasculopathy in CTEPH
Overview
This study utilized high-resolution photon-counting detector CT (PCD-CT) to identify morphological changes in the lung microvasculature of 29 patients with chronic thromboembolic pulmonary hypertension (CTEPH). Findings revealed distinct alterations in small pulmonary vessels corresponding to areas of hypo- and hyper-attenuation on mosaic perfusion patterns, suggesting PCD-CT’s potential in visualizing microvascular disease previously undetectable by conventional imaging.
Background
CTEPH is characterized by fibrotic transformation of unresolved clots in pulmonary arteries and small-vessel arteriopathy involving arterioles, venules, and capillaries. While central and peripheral lesions can be treated surgically or interventionally, small-vessel disease remains inaccessible and contributes to residual pulmonary hypertension after treatment. Indirect imaging clues such as poor subpleural perfusion have suggested microvascular involvement, but direct morphological visualization has been limited by CT resolution. The advent of PCD-CT offers enhanced spatial resolution, enabling investigation of subtle microvascular changes in CTEPH.
Data Highlights
Parameter
Value
Number of patients
29
Scanning collimation
120 × 0.2 mm (20 patients), 144 × 0.4 mm (9 patients)
Image reconstruction
Polychromatic 0.2 mm or 70-keV 0.4 mm with QIR4/QIR3 iterative reconstruction
Inclusion criteria
Confirmed PH by right-heart catheterization, CTEPH diagnosis, mosaic perfusion pattern on CTA
Key Findings
PCD-CT enabled visualization of morphological changes in small pulmonary vessels in CTEPH patients.
Mosaic perfusion pattern areas showed distinct vascular alterations: enlarged vessels in hyper-attenuated regions and smaller vessels in hypo-attenuated regions.
Small-vessel arteriopathy was detectable morphologically, correlating with areas of perfusion redistribution and obstruction.
Findings support the presence of microvascular disease contributing to elevated pulmonary vascular resistance in CTEPH.
PCD-CT imaging may provide a novel non-invasive method to assess microvascular involvement in CTEPH beyond conventional imaging limits.
Clinical Implications
The ability of PCD-CT to detect lung microvasculopathy in CTEPH patients offers clinicians a new tool to evaluate the extent of small-vessel disease non-invasively. This may improve risk stratification, guide therapeutic decisions including the use of pulmonary arterial hypertension medications, and help predict residual pulmonary hypertension after surgical or interventional treatment. Incorporating PCD-CT imaging could enhance comprehensive assessment of CTEPH beyond central and peripheral artery lesions.
Conclusion
High-resolution PCD-CT imaging reveals morphological evidence of lung microvasculopathy in CTEPH, previously undetectable by standard CT. This advancement holds promise for improved diagnosis and management of microvascular disease in this patient population.
References
Study Authors/Institution/2024 -- High-Resolution Photon-Counting Detector CT Findings of Lung Microvasculopathy in Patients with Chronic Thromboembolic Pulmonary Hypertension
